Alpine Immune Sciences Inc (ALPN)
64.60
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
64.60
0.00 (0.00%)
After-Hours: 20:00
Alpine Immune Sciences Total Assets (Quarterly): 379.85M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 379.85M |
| September 30, 2023 | 240.55M |
| June 30, 2023 | 252.84M |
| March 31, 2023 | 262.10M |
| December 31, 2022 | 286.69M |
| September 30, 2022 | 291.60M |
| June 30, 2022 | 215.83M |
| March 31, 2022 | 233.94M |
| December 31, 2021 | 255.90M |
| September 30, 2021 | 233.48M |
| June 30, 2021 | 159.82M |
| March 31, 2021 | 129.98M |
| December 31, 2020 | 144.09M |
| September 30, 2020 | 154.03M |
| June 30, 2020 | 102.70M |
| March 31, 2020 | 49.85M |
| December 31, 2019 | 54.09M |
| September 30, 2019 | 64.74M |
| June 30, 2019 | 70.09M |
| Date | Value |
|---|---|
| March 31, 2019 | 67.10M |
| December 31, 2018 | 54.87M |
| September 30, 2018 | 64.51M |
| June 30, 2018 | 73.12M |
| March 31, 2018 | 80.70M |
| December 31, 2017 | 85.22M |
| September 30, 2017 | 90.79M |
| June 30, 2017 | 49.64M |
| March 31, 2017 | 53.01M |
| December 31, 2016 | 61.94M |
| September 30, 2016 | 67.34M |
| June 30, 2016 | 74.56M |
| March 31, 2016 | 80.94M |
| December 31, 2015 | 87.91M |
| September 30, 2015 | 93.84M |
| June 30, 2015 | 101.25M |
| March 31, 2015 | 26.30M |
| December 31, 2014 | 28.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
49.85M
Minimum
Mar 2020
379.85M
Maximum
Dec 2023
188.53M
Average
215.83M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 22.73B |
| Eliem Therapeutics Inc | 110.47M |
| Regeneron Pharmaceuticals Inc | 34.37B |
| Vera Therapeutics Inc | 175.55M |
| Eyenovia Inc | 28.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.91M |
| Shareholders Equity (Quarterly) | 327.94M |
| Current Ratio | 7.862 |
| Net Debt Paydown Yield | 0.08% |